Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Clinical Trials - Key findings Type 2 diabetes (40 weeks): HbA1c 1.241.48% (vs 0.41% placebo) Weight loss 4.57.6% (vs 1.7% placebo) Obesity without diabetes (72 weeks): Mean weight loss 11.2% 54.6% achieved 10% weight loss Improved cardiometabolic markers Efficacy similar to semaglutide/liraglutide (slightly less than tirzepatide) Safety: GI effects most common (during dose escalation) Low discontinuation rates No major hypoglycemia, hepatic, or CV safety signals so far Orforglipron combines oral convenience + GLP-1level efficacy, with the potential to improve access, adherence, and long-term outcomes in diabetes and obesity management
Wu Z, Li X, Wen Q, Tao B, Qiu B, Zhang Q
Kudzu root and N-Acetyl Cysteine supplements have some research support
[DOI] [PMC free article] [PubMed] [Google Scholar] [10].Singh RP, Hahn BH, Bischoff DS
RESEARCH GRADE
US$ 29.65
US$ 27.62
US$ 27.66
US$ 29.05
US$ 28.17
US$ 20.14
